Eisai Presents Latest Data of Phase I Clinical Trial on Liposomal Formulation of Anti-Cancer Agent Halaven (Eribulin) at ESMO Virtual Congress 2020
- Written by ACN Newswire - Press Releases
.
More Articles ...
- AVIA Hosts the Satellite Industry Forum Focusing on Video in the Satellite World
- Fujitsu Develops Technology to Block Facial Authentication Fraud
- TAITRA's Smart Manufacturing Webinar a Success, Captures Worldwide Buyer Attention
- The REL Token is Listed on CoinsBit and AzBit Cryptocurrency Exchanges. We, Release Project, Will Transform the Logistics of Agriculture and Fisheries Around the World
- Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance
- Tiger Brokers adds ASX to its Online Trading Mobile App
- Denyo and Toyota Jointly Develop and Start Verification Tests for Fuel Cell Power Supply Vehicle that Uses Hydrogen to Generate Electricity
- DoiT Signs Multi-Year, Strategic, Non-Binding 1.5 Billion Dollar Agreement with Google Cloud
- Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
- CENTRESTAGE Virtual Runway Shows Begin Today
Magazine
How Long Does Botox Really Last? A Realistic Timeline
Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...
Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know
Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...
Common Risks Hidden in Commercial Lease Agreements
Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...